Literature DB >> 12145280

The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein.

Patricia McLoughlin1, Elisabeth Ehler, Graeme Carlile, Jonathan D Licht, Beat W Schäfer.   

Abstract

Members of the four-and-a-half-LIM domain (FHL) protein family, which are expressed in a tissue- and stage-specific manner, have been reported previously to function as transcriptional coactivators. One of these is the p53-inducible protein DRAL/FHL2 (where DRAL is down-regulated in rhabdomyosarcoma LIM domain protein). In this work, we identified potential binding partners for DRAL/FHL2 using an inducible yeast two-hybrid system. We present evidence of a functional interaction between the promyelocytic leukemia zinc finger protein (PLZF) and DRAL/FHL2. PLZF is a sequence-specific transcriptional repressor whose function relies on recruitment of corepressors that form part of the histone deacetylase complex involved in chromatin remodeling. DRAL/FHL2 interacts specifically with PLZF in vitro and in vivo and augments transcriptional repression mediated by PLZF. This is the first reported incidence of a bona fide FHL protein-mediated corepression and supports the notion of these proteins having a role as coregulators of tissue-specific gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145280     DOI: 10.1074/jbc.M203336200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  M-band: a safeguard for sarcomere stability?

Authors:  Irina Agarkova; Elisabeth Ehler; Stephan Lange; Roman Schoenauer; Jean-Claude Perriard
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

2.  Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes.

Authors:  Nicole H Purcell; Dina Darwis; Orlando F Bueno; Judith M Müller; Roland Schüle; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

3.  The expression pattern of FHL2 during mouse molar development.

Authors:  Jianxin Du; Qiang Wang; Li Wang; Xiaoying Wang; Pishan Yang
Journal:  J Mol Histol       Date:  2012-03-30       Impact factor: 2.611

4.  FHL2 mediates tooth development and human dental pulp cell differentiation into odontoblasts, partially by interacting with Runx2.

Authors:  Jianxin Du; Qiang Wang; Pishan Yang; Xiaoying Wang
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

Review 5.  The family feud: turning off Sp1 by Sp1-like KLF proteins.

Authors:  Gwen Lomberk; Raul Urrutia
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

6.  Differential regulation of Hand1 homodimer and Hand1-E12 heterodimer activity by the cofactor FHL2.

Authors:  Alison A Hill; Paul R Riley
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

7.  Site-specific proteolysis of the transcriptional coactivator HCF-1 can regulate its interaction with protein cofactors.

Authors:  Jodi L Vogel; Thomas M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-19       Impact factor: 11.205

8.  Ajuba functions as a histone deacetylase-dependent co-repressor for autoregulation of the growth factor-independent-1 transcription factor.

Authors:  Diego E Montoya-Durango; Chinavenmeni S Velu; Avedis Kazanjian; Meghan E B Rojas; Chris M Jay; Gregory D Longmore; H Leighton Grimes
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

9.  Immunohistochemical localization of four and a half LIM domains 2 in the odontoblasts of mature human teeth.

Authors:  Xiaoying Wang; Qiang Wang; Li Wang; Pishan Yang
Journal:  J Mol Histol       Date:  2011-02-10       Impact factor: 2.611

10.  Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.

Authors:  Charlotte Labalette; Yann Nouët; Florence Levillayer; Sabine Colnot; Ju Chen; Valere Claude; Michel Huerre; Christine Perret; Marie-Annick Buendia; Yu Wei
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.